AccScience Publishing / GPD / Volume 3 / Issue 4 / DOI: 10.36922/gpd.4076
Submit to GPD
Cite this article
12
Download
248
Views
Journal Browser
Volume | Year
Issue
Search
Forthcoming Issue
Current Issue
View All
News and Announcements
View All
ORIGINAL RESEARCH ARTICLE

Interleukin-1β, interleukin-1Ra, and interleukin-8 in patients with SARS-CoV-2 infection: A correlation between vaccination and clinical outcome

Laine Andreotti Almeida1,2 ,  Mikaela Nagahara3 ,  Manuela dos Santos Bueno1 ,  Mônica Pezenatto Santos1 ,  Roger Labio1 ,  Spencer Luiz Marques Payão1 ,  Lucas Trevizani Rasmussen1,3*
Show Less
1 Faculdade de Medicina de Marilia (FAMEMA) - Hemocentro, Genetics Laboratory, Marília, São Paulo, Brazil
2 Department of Veterinary Medicine, Universidade de Marília – UNIMAR, Marília, São Paulo, Brazil
3 Centro Universitário de Ourinhos – UNIFIO, Ourinhos, São Paulo, Brazil
GPD 2024, 3(4), 4076 https://doi.org/10.36922/gpd.4076
Submitted: 29 June 2024 | Accepted: 24 September 2024 | Published: 4 November 2024
© 2024 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Download PDF
Cite
XML
Abstract

Coronavirus disease 2019 (COVID-19), an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was responsible for the pandemic decreed on March 11, 2020. Here, we investigated the mRNA expression of interleukin (IL)-1β, IL-8, and IL-1RN in samples collected from patients with and without SARS-CoV-2 infection, who were vaccinated or unvaccinated. This investigation was designed as a qualitative, cross-sectional, comparative, and randomized observational study. Samples were collected through nasal/oral swabs from patients symptomatic for influenza syndrome or SARS. Patients were categorized into three groups: DVAC (patients with SARS-CoV-2 infection and vaccinated), DNVAC (patients with SARS-CoV-2 infection and not vaccinated), and ND (patients without SARS-CoV-2 infection). SARS-CoV-2 was detected through reverse transcription polymerase chain reaction (RT-PCR). Gene expressions of IL-1β, IL-8, and IL-1RN were also evaluated using RT-PCR. Statistically significant differences in IL-8 expression were observed among the study groups (P = 0.033); moreover, clinical signs and symptoms, frequency of hospitalizations, and need for intensive care units showed significant differences. These differences were noted in the DVAC group compared with those in the DNVAC and ND groups. Patients with COVID-19 showed reduced IL-8 expression compared with those with other diseases that also cause influenza syndrome or SARS. These results suggested that the severity of clinical manifestations of patients with COVID-19 reduced after the initial two doses of the CoronaVac/Sinovac vaccine. Moreover, this vaccine reduced mortality and lethality in patients with SARS-CoV-2 infection.

Keywords
Severe acute respiratory syndrome coronavirus 2
Coronavirus disease 2019
Gene expression
Interleukins
Vaccination
Funding
This study was supported by the Sao Paulo Research Foundation (FAPESP) (case numbers: 2018/08481-1 and 2021/12017-1).
Conflict of interest
The authors declare they have no competing interests.
References
  1. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8

 

  1. Sohrabi C, Alsafi Z, O’Neill N, et al. Corrigendum to “World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)”. Int J Surg. 2020;77:217. doi: 10.1016/j.ijsu.2020.02.034

 

  1. De Souza WV, Martelli CMT, Silva AP, et al. The first hundred days of COVID-19 in Pernambuco State, Brazil: Epidemiology in historical context. Cad Saude Publica. 2020;36(11):e00228220. doi: 10.1590/0102-311X00228220

 

  1. Aquino EML, Silveira IH, Pescarini JM, et al. Social distancing measures to control the COVID-19 pandemic: Potential impacts and challenges in Brazil. Cien Saude Colet. 2020;25:2423-2446. doi: 10.1590/1413-81232020256.1.10502020

 

  1. Governo de Santa Catarina, Secretaria de Estado da Saúde, Sistema Único de Saúde, Superintendência de Vigilância em Saúde, Diretoria de Vigilância Epidemiológica de Santa Catarina. Manual De Orientações Da Covid-19 (Vírus SARS-CoV-2). Florianópolis: 2020.

 

  1. Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020;39(5):405-407. doi: 10.1016/j.healun.2020.03.012

 

  1. Bakhiet M, Taurin S. SARS-CoV-2: Targeted managements and vaccine development. Cytokine Growth Factor Rev. 2021;58:16-29. doi: 10.1016/j.cytogfr.2020.11.001

 

  1. Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol. 2020;41(12):1100-1115. doi: 10.1016/j.it.2020.10.004

 

  1. Kirtipal N, Bharadwaj S, Kang SG. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses. Infect Genet Evol. 2020;85:104502. doi: 10.1016/j.meegid.2020.104502

 

  1. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994

 

  1. Zhang W, Zhao Y, Zhang F, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The perspectives of clinical immunologists from China. Clin Immunol. 2020;214:108393. doi: 10.1016/j.clim.2020.108393

 

  1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5

 

  1. de Oliveira CM, Sakata RK, Issy AM, Gerola LR, Salomão R. Cytokines and pain. Rev Bras Anestesiol. 2011; 61: 2: 255- 265.

 

  1. Kraychete D, Calasans M, Valente C. Pro-inflammatory cytokines and pain. Rev Bras Reumatol. 2006;3(43):199-206. doi: 10.1590/S0482-50042006000300007

 

  1. Varella P, Forte W. Citokines: A review. Rev Bras Alergia Imunopatol. 2001;4:146-155.

 

  1. Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007;45(2):27-37. doi: 10.1097/AIA.0b013e318034194e

 

  1. Raghuwanshi SK, Su Y, Singh V, Haynes K, Richmond A, Richardson RM. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions. J Immunol. 2012;189(6):2824-2832. doi: 10.4049/jimmunol.1201114

 

  1. Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: Viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021;21(10):626-636. doi: 10.1038/s41577-021-00592-1

 

  1. Santos-Pinto CDB, Miranda ES, Osorio-de-Castro CGS. “Kit-covid” and the Popular Pharmacy Program in Brazil. Cad Sáude Pública. 2021;2:1-5.

 

  1. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-408. doi: 10.1006/meth.2001.1262

 

  1. Wong CK, Lam CW, Wu AK, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol. 2004;136(1):95-103. doi: 10.1111/j.1365-2249.2004.02415.x

 

  1. Pascarella G, Strumia A, Piliego C, et al. COVID-19 diagnosis and management: A comprehensive review. J Intern Med. 2020;288(2):192-206. doi: 10.1111/joim.13091

 

  1. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7

 

  1. Moreira RS. Latent class analysis of COVID-19 symptoms in Brazil: Results of the PNAD-COVID19 survey. Cad Saúde Pública. 2021;37:14. doi: 10.1590/0102-311x00238420

 

  1. Butatã I. Não Vacinados Representam 75% das Mortes por Covid-19, Diz Estudo Brasileiro. São Paulo: Instituto Butantan; 2022.

 

  1. Martins WA, de Oliveira GMM, Brandão AA, et al. Vaccinating patients with heart disease against COVID-19: The reasons for priority. Arq Bras Cardiol. 2021;116(2):213-218. doi: 10.36660/abc.20210012

 

  1. Orellana JDY, Cunha GMd, Leite LMdC, Domingues CMA, Horta BL. Changes in the pattern of COVID-19 hospitalizations and deaths after substantial vaccination of the elderly in Manaus, Amazonas State, Brazil. Cad Saúde Pública. 2022;38:PT192321. doi: 10.1590/0102-311XPT192321

 

  1. Barbosa AV, da Silva SM, da Silva FH, de Assunção MAS, dos Anjos FBR. Características clínicas da COVID-19. In: Latin American Publicações, editor. Fatores de Virulência Microbianos e Terapias Emergentes. Vol. 3. São José dos Pinhais: Latin American Publicações; 2022. p. 355.

 

  1. Das Mercês SO, Lima FLO, de Vasconcellos Neto JRT. Association of COVID-19 with: Age and medical comorbidities. Res Soc Dev. 2020;9:e1299108285. doi: 10.33448/rsd-v9i10.8285

 

  1. Tang D, Comish P, Kang R. The hallmarks of COVID-19 disease. PLoS Pathog. 2020;16(5):e1008536. doi: 10.1371/journal.ppat.1008536

 

  1. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-260. doi: 10.1038/s41569-020-0360-5

 

  1. Figueira K. COVID-19 em pacientes com câncer: COVID- 19 in cancer patients: Managing a pandemic within a pandemic. Braz J Implantol Health Sci. 2020;2:6. doi: 10.36557/2674-8169.2020v2n12p01-06

 

  1. De Sousa EL, Gaído SB, de Sousa RA, et al. Profile of hospital admissions and deaths due to severe acute respiratory syndrome caused by COVID-19 in Piauí, Brazil: A descriptive study, 2020-2021. Epidemiol Serv Saúde. 2022;31:e2021836. doi: 10.1590/s1679-49742022000100009

 

  1. Ranzani OT, Bastos LSL, Gelli JBM, et al. Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: A retrospective analysis of nationwide data. Lancet Respir Med. 2021;9(4):407-418. doi: 10.1016/S2213-2600(20)30560-9
Share
Back to top
Gene & Protein in Disease, Electronic ISSN: 2811-003X Published by AccScience Publishing
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept